PDS Biotechnology Corp (PDSB)
3.37
-0.16
(-4.53%)
USD |
NASDAQ |
May 20, 16:00
3.37
0.00 (0.00%)
After-Hours: 18:02
PDS Biotechnology Cash from Operations (Quarterly): -9.938M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -9.938M |
December 31, 2023 | -8.457M |
September 30, 2023 | -7.176M |
June 30, 2023 | -4.814M |
March 31, 2023 | -13.19M |
December 31, 2022 | -7.529M |
September 30, 2022 | -5.893M |
June 30, 2022 | -5.919M |
March 31, 2022 | -6.369M |
December 31, 2021 | -4.501M |
September 30, 2021 | -5.129M |
June 30, 2021 | 0.9462M |
March 31, 2021 | -3.802M |
December 31, 2020 | -4.629M |
September 30, 2020 | -1.252M |
June 30, 2020 | -4.103M |
March 31, 2020 | -3.164M |
December 31, 2019 | -5.520M |
September 30, 2019 | -4.328M |
Date | Value |
---|---|
June 30, 2019 | -4.859M |
March 31, 2019 | -3.367M |
December 31, 2018 | -31.90M |
September 30, 2018 | -0.4322M |
June 30, 2018 | -0.4154M |
March 31, 2018 | -0.4043M |
December 31, 2017 | -9.240M |
September 30, 2017 | -11.40M |
June 30, 2017 | -9.284M |
March 31, 2017 | -10.77M |
December 31, 2016 | -6.046M |
September 30, 2016 | -8.793M |
June 30, 2016 | -8.275M |
March 31, 2016 | -9.074M |
December 31, 2015 | -6.783M |
September 30, 2015 | -4.999M |
June 30, 2015 | -5.706M |
March 31, 2015 | -4.265M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-13.19M
Minimum
Mar 2023
0.9462M
Maximum
Jun 2021
-5.481M
Average
-4.994M
Median
Cash from Operations (Quarterly) Benchmarks
Syros Pharmaceuticals Inc | -31.10M |
PAVmed Inc | -13.11M |
Palatin Technologies Inc | -8.607M |
iBio Inc | -4.706M |
Chromocell Therapeutics Corp | -0.2572M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 20.01M |
Free Cash Flow | -30.39M |
Free Cash Flow Per Share (Quarterly) | -0.2855 |
Free Cash Flow Yield | -28.13% |